Merck Balance Sheet Health

Financial Health criteria checks 4/6

Merck has a total shareholder equity of $37.6B and total debt of $35.1B, which brings its debt-to-equity ratio to 93.1%. Its total assets and total liabilities are $106.7B and $69.0B respectively. Merck's EBIT is $4.6B making its interest coverage ratio 5.8. It has cash and short-term investments of $7.1B.

Key information

93.1%

Debt to equity ratio

US$35.06b

Debt

Interest coverage ratio5.8x
CashUS$7.09b
EquityUS$37.64b
Total liabilitiesUS$69.04b
Total assetsUS$106.68b

Recent financial health updates

No updates

Recent updates

Merck's Future Brightens With Winrevair's Blockbuster Potential

Mar 27

Merck: A High-Conviction Investment For Long-Term Growth

Feb 29

Merck: Big Pharma Looks Stronger Than Ever Ahead Of 2023 Earnings

Jan 29

Is Merck & Co., Inc. (NYSE:MRK) Trading At A 47% Discount?

Jan 26
Is Merck & Co., Inc. (NYSE:MRK) Trading At A 47% Discount?

Merck's Soaring Stock: Examining The Euphoria Amidst Potential Pitfalls

Jan 08

Merck: One Of The Best - Unveiling The Trifecta Of Safety, Dividends, And Growth

Dec 25

Merck (NYSE:MRK) Is Increasing Its Dividend To $0.77

Dec 08
Merck (NYSE:MRK) Is Increasing Its Dividend To $0.77

Financial Position Analysis

Short Term Liabilities: MRK's short term assets ($32.2B) exceed its short term liabilities ($25.7B).

Long Term Liabilities: MRK's short term assets ($32.2B) do not cover its long term liabilities ($43.3B).


Debt to Equity History and Analysis

Debt Level: MRK's net debt to equity ratio (74.3%) is considered high.

Reducing Debt: MRK's debt to equity ratio has reduced from 93.7% to 93.1% over the past 5 years.

Debt Coverage: MRK's debt is well covered by operating cash flow (37.1%).

Interest Coverage: MRK's interest payments on its debt are well covered by EBIT (5.8x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.